Expanded Label For Sanofi Pasteur's Menactra May Lead To Only Limited Market

FDA has extended approval of the meningococcal disease vaccine to children as young as nine months, but if the CDC recommends it only for high-risk groups the expanded market could be limited.

More from Archive

More from Pink Sheet